- ABOUT JSMO
- HOME
- ABOUT JSMO
- 2018 Award Recipients
2018 Award Recipients
2018 Award Recipients
Annals of Oncology Award | ||
---|---|---|
Name | Affiliation | Awarded Paper |
Kaoru Kubota | Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School | A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial Annals of Oncology, Volume 26, Issue 7, 1 July 2015, Pages 1401-1408, |
Young Investigator Award | ||
Name | Affiliation | Title |
Yoshinori Imamura | Department of Medical Oncology and Hematology, Kobe University Hospital | Docetaxel plus Cisplatin in Recurrent and/or Metastatic Non-squamous Cell Carcinoma of Head and Neck: a Phase II Trial |
Kazunori Honda | Department of Clinical Oncology, Aichi Cancer Center Hospital | A prospective survey of COmprehensive Score for financial Toxicity (COST) in Japanese cancer patients |
Koji Haratani | Department of Medical Oncology, Kindai University Faculty of Medicine | Tumor immune microenvironment and prognosis of cancer of unknown primary |
Yusuke Kanemasa | Department of Medical Oncology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital | Geriatric nutritional risk index as a prognostic factor in patients with diffuse large B cell lymphoma |
Jumpei Takeshita | Genome Science Division, Research Center for Advanced Science and Technology, the University of Tokyo | Comprehensive molecular characterization of malignant pleural mesothelioma |
Kei Kunimasa | Department of Thoracic Oncology, Osaka International Cancer Institute | Immuno-oncology biomarker study in a large cohort of LC-SCRUM-Japan:LC-SCRUM-IBIS |
Jia Wei | The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University & Clinical Cancer Institute of Nanjing University |
Targeted-sequencing and comprehensive molecular profiling of gastric signet ring cell carcinoma |
Musadiq Ahmad Bhat | maulana azad medical college | Aberrant promoter methylation ofcell cycle genes is associated with disease progression and molecular response CMLpatients |
※Titles omitted, listed in Japanese alphabetical order.
※Affiliations are listed as of the time of the award.
Scenes from the Award Ceremony
※Click to view a larger image.